GUT MICROBIOTA PARTICIPATE IN THE RESISTANCE OF BID-DEFICIENT MICE TO DIET-INDUCED HEPATIC STEATOSIS AND OBESITY

被引：0
|
作者：
Yan, Shengmin [1 ]
Chen, Xiaoyun [1 ]
Yin, Xiao-Ming [1 ]
机构：
[1] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1931
引用
收藏
页码：1155A / 1155A
页数：1
相关论文
共 50 条
  • [1] Dietary Phaseolus vulgaris extract alleviated diet-induced obesity, insulin resistance and hepatic steatosis and alters gut microbiota composition in mice
    Song, Haizhao
    Han, Wen
    Yan, Fujie
    Xu, Dongdong
    Chu, Qiang
    Zheng, Xiaodong
    JOURNAL OF FUNCTIONAL FOODS, 2016, 20 : 236 - 244
  • [2] Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in association with modulation of gut microbiota in mice
    Li, Shuo
    You, Jinming
    Wang, Zirui
    Liu, Yue
    Wang, Bo
    Du, Min
    Zou, Tiande
    Food Research International, 2021, 143
  • [3] Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in association with modulation of gut microbiota in mice
    Li, Shuo
    You, Jinming
    Wang, Zirui
    Liu, Yue
    Wang, Bo
    Du, Min
    Zou, Tiande
    FOOD RESEARCH INTERNATIONAL, 2021, 143
  • [4] Empagliflozin protects from diet-induced obesity, insulin resistance and hepatic steatosis in mice
    Radlinger, B.
    Ress, C.
    Folie, S.
    Salzmann, K.
    Salvenmoser, W.
    Graber, M.
    Hirsch, J.
    Holfeld, J.
    Kremser, C.
    Moser, P.
    Staudacher, G.
    Jelenik, T.
    Roden, M.
    Tilg, H.
    Kaser, S.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S295 - S295
  • [5] Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
    Bernhard Radlinger
    Claudia Ress
    Sabrina Folie
    Karin Salzmann
    Ana Lechuga
    Bernhard Weiss
    Willi Salvenmoser
    Michael Graber
    Jakob Hirsch
    Johannes Holfeld
    Christian Kremser
    Patrizia Moser
    Gabriele Staudacher
    Tomas Jelenik
    Michael Roden
    Herbert Tilg
    Susanne Kaser
    Diabetologia, 2023, 66 : 754 - 767
  • [6] Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
    Radlinger, Bernhard
    Ress, Claudia
    Folie, Sabrina
    Salzmann, Karin
    Lechuga, Ana
    Weiss, Bernhard
    Salvenmoser, Willi
    Graber, Michael
    Hirsch, Jakob
    Holfeld, Johannes
    Kremser, Christian
    Moser, Patrizia
    Staudacher, Gabriele
    Jelenik, Tomas
    Roden, Michael
    Tilg, Herbert
    Kaser, Susanne
    DIABETOLOGIA, 2023, 66 (04) : 754 - 767
  • [7] Promotion of diet-induced obesity and metabolic syndromes by BID is associated with gut microbiota
    Yan, Shengmin
    Zhou, Jun
    Zhang, Hao
    Lin, Zhen
    Khambu, Bilon
    Liu, Gang
    Ma, Michelle
    Chen, Xiaoyun
    Chalasani, Naga
    Yin, Xiao-Ming
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (12) : 3349 - 3362
  • [8] Pectic oligosaccharides ameliorate high-fat diet-induced obesity and hepatic steatosis in association with modulating gut microbiota in mice
    Yu, Shengnan
    Wang, Haoyu
    Cui, Luwen
    Wang, Jingyi
    Zhang, Zixuan
    Wu, Zhinan
    Lin, Xiaoqian
    He, Ningning
    Zou, Yuanqiang
    Li, Shangyong
    FOOD & FUNCTION, 2023, 14 (21) : 9892 - 9906
  • [9] Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice
    Krumm, Christopher S.
    Xu, Xu
    Bare, Curtis J.
    Holman, Corey D.
    Kersten, Sander
    Dow, Lukas E.
    Lee, Ann-Hwee
    Cohen, David E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 297 (01)
  • [10] BID-DEFICIENCY ALTERS HEPATIC METABOLOME AND LEADS TO RESISTANCE TO DIET-INDUCED HEPATIC STEATOSIS
    Yan, Shengmin
    Lin, Zhen
    Ma, Michelle
    Yin, Xiao-Ming
    HEPATOLOGY, 2021, 74 : 1056A - 1057A
12345